 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Dehydrogenases [EC:1.1.1.-]
|
Oxidases [EC:1.1.3.-]
|
Dehydrogenases [EC:1.2.1.-]
|
Dehydrogenases [EC:1.3.-.-]
|
DPYD [HSA:1806] [KO:K00207]
|
SRD5A1 [HSA:6715] [KO:K12343]
|
SRD5A2 [HSA:6716] [KO:K12344]
|
SRD5A3 [HSA:79644] [KO:K12345]
|
DHODH [HSA:1723] [KO:K00254]
|
 D00749 Leflunomide (JAN/USP/INN) <JP/US>
D10172 Teriflunomide (USAN) <US>
D03154 Brequinar sodium (USAN)
D11890 Emvododstat (USAN)
|
Amine oxidases [EC:1.4.3.-]
|
Dihydrofolate reductase [EC:1.5.1.3]
|
NAD(P)H dehydrogenase [EC:1.6.5.2]
|
Peroxidase [EC:1.11.1.-]
|
Peroxygenase [EC:1.11.2.-]
|
Dioxygenases [EC:1.13.11.-]
|
Prolyl 4-hydroxylase [EC:1.14.11.2]
|
HIF hydroxylase [EC:1.14.11.29]
|
Nitic oxide synthase [EC:1.14.13.39]
|
Cytochrome P450 [EC:1.14.14.-]
|
Other monooxygenases [EC:1.14.16.- 1.14.17.- 1.14.18.-]
|
Prostaglandin synthase [EC:1.14.99.1]
|
Histone demethylase [EC:1.14.99.66]
|
Superoxide dismutase [EC:1.15.1.1]
|
Xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
|
Ribonucleoside-diphosphate reductase [EC:1.17.4.1]
|
Vitamin-K-epoxide reductase [EC:1.17.4.4]
|
Thyroxine 5'-deiodinase [EC:1.21.99.4]
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs